Skip to main content

Table 2 Summary of CARM1 genetic alteration and clinical survival prognosis in various cancers cases

From: Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

Tumor types Sample size P
OS PFS DSS DFS
BLCA 562 0.743 NA NA 0.0465
BRCA 963 0.793 NA NA 0.469
CESC 278 0.883 0.0239 0.87 0.00003
COAD 436 0.521 0.0202 0.845 0.0314
SKCM 363 0.077 0.191 0.145 NA
GBM 378 0.356 0.501 0.273 NA
HNSC 385 0.0012 NA NA NA
LUAD 230 0.334 NA NA 0.055
LUSC 469 0.62 0.44 0.263 0.583
PRAD 489 0.515 0.29 0.667 0.0432
STAD 434 0.0315 0.277 0.132 0.448
UCS 509 0.535 0.147 0.298 0.263
  1. P value derived from Log Rank test. The bold font indicates that the prognosis of the mutated group is worse than that of the non-mutated group. NS, P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001